Physician profile
Kathryn Bower
NPI 1295175883
$21,132.41
in general payments reported to CMS, 2019-2025
90 companies · $4,933 in 2025
The $4,933 reported for 2025 was more than what 82% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $99.54 · 2020: $1,168 · 2021: $2,697 · 2022: $3,625 · 2023: $4,084 · 2024: $4,527 · 2025: $4,933.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $13K · Education: $300.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $13,243.18 |
| Education | $300.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,674.73 | 2020-2025 | |
| Pfizer INC. | $1,204.11 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $1,122.30 | 2020-2025 | Imfinzi, Enhertu, Calquence |
| Janssen Biotech, INC. | $1,034.53 | 2021-2025 | Erleada, Darzalex, Imbruvica |
| Merck Sharp & Dohme LLC | $991.18 | 2020-2025 | Keytruda, Welireg, Lynparza |
| Daiichi Sankyo INC. | $907.69 | 2020-2025 | Enhertu, Injectafer, Datroway |
| Incyte Corporation | $860.54 | 2019-2025 | Jakafi, Monjuvi, Niktimvo |
| Celgene Corporation | $715.68 | 2020-2025 | Reblozyl, Opdualag, Pomalyst |
| Eisai INC. | $637.71 | 2020-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $627.64 | 2021-2025 | Fruzaqla, Ninlaro, Iclusig |
| Lilly USA, LLC | $619.04 | 2020-2025 | Verzenio, Jaypirca, Retevmo |
| Gilead Sciences, INC. | $596.41 | 2021-2025 | Trodelvy |
| Glaxosmithkline, LLC. | $508.75 | 2022-2025 | Ojjaara, Zejula, Jemperli |
| Sobi, INC | $463.98 | 2022-2025 | |
| E.R. Squibb & Sons, L.L.C. | $449.76 | 2021-2025 | Opdivo, Opdualag |
Show all 90 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $417.55 | 2021-2025 | Tecentriq, Polivy, Alecensa |
| Abbvie INC. | $391.38 | 2020-2025 | Venclexta |
| Beigene USA, INC. | $386.12 | 2020-2025 | Brukinsa |
| Aveo Pharmaceuticals, INC. | $385.77 | 2021-2025 | Fotivda |
| Seagen INC. | $382.18 | 2020-2023 | Tukysa, Padcev, Tivdak |
| Jazz Pharmaceuticals INC. | $308.10 | 2020-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $304.37 | 2021-2025 | Gilotrif |
| Astellas Pharma US INC | $302.54 | 2020-2025 | Padcev, Vyloy, Xospata |
| Regeneron Healthcare Solutions, INC. | $291.12 | 2021-2025 | Libtayo |
| Bayer Healthcare Pharmaceuticals INC. | $272.57 | 2020-2025 | |
| Servier Pharmaceuticals LLC | $272.48 | 2021-2025 | |
| Array Biopharma INC | $267.93 | 2021-2025 | Braftovi, Mektovi, Lorbrena |
| Rigel Pharmaceuticals, INC. | $258.87 | 2020-2024 | Rezlidhia, Tavalisse |
| Genzyme Corporation | $258.73 | 2021-2025 | |
| Foundation Medicine, INC. | $230.39 | 2020-2022 | |
| Puma Biotechnology, INC. | $188.19 | 2021-2025 | |
| Pharmacosmos Therapeutics INC. | $184.06 | 2020-2025 | Monoferric |
| Karyopharm Therapeutics INC. | $166.35 | 2020-2024 | Xpovio |
| Emd Serono, INC. | $155.24 | 2021-2025 | Bavencio |
| Kite Pharma, INC. | $144.99 | 2021-2023 | Yescarta |
| Dova Pharmaceuticals | $123.13 | 2020-2021 | |
| Sumitomo Pharma America, INC. | $118.63 | 2023-2025 | Orgovyx |
| Myriad Genetic Laboratories, INC. | $116.68 | 2020-2025 | Myrisk |
| Geron Corporation | $113.45 | 2025 | Rytelo |
| Exelixis INC. | $113.23 | 2020-2023 | Cabometyx |
| Pharmacyclics LLC, An Abbvie Company | $112.46 | 2021-2023 | Imbruvica |
| Sun Pharmaceutical Industries INC. | $104.85 | 2020-2023 | Yonsa, Odomzo |
| Myovant Sciences INC. | $102.40 | 2021-2022 | |
| Stemline Therapeutics INC. | $101.52 | 2023-2025 | Orserdu |
| Agios Pharmaceuticals, INC. | $98.41 | 2020-2024 | Pyrukynd |
| Tempus Ai, INC | $91.76 | 2024-2025 | Xt Cdx |
| Pharmaessentia USA Corporation | $91.35 | 2023-2025 | Besremi |
| Intera Oncology, INC | $81.64 | 2023 | Intera 3000 Implantable Pump |
| Acrotech Biopharma INC. | $79.46 | 2022-2025 | Beleodaq, Ryzneuta |
| Amneal Pharmaceuticals LLC | $78.53 | 2023-2025 | Neulasta, Avastin, Neupogen |
| Immunomedics, INC. | $76.55 | 2020 | |
| Genmab U.S., INC. | $71.25 | 2023-2025 | Epkinly |
| Kyowa Kirin, INC. | $70.05 | 2021-2025 | Poteligeo |
| Legend Biotech USA INC. | $66.42 | 2025 | Carvykti |
| Global Blood Therapeutics, INC. | $63.14 | 2020-2022 | |
| Mirati Therapeutics, INC. | $61.89 | 2023 | Krazati |
| Caris Mpi, INC. | $60.80 | 2025 | Mi Cancer Seek |
| Adc Therapeutics America, INC. | $60.42 | 2022-2025 | |
| Cti Biopharma Corp. | $58.68 | 2022-2023 | Vonjo |
| Tersera Therapeutics LLC | $58.68 | 2022-2025 | Zoladex |
| Deciphera Pharmaceuticals INC. | $56.59 | 2021-2025 | Romvimza, Qinlock |
| Taiho Oncology, INC. | $54.77 | 2024 | |
| Epizyme, INC. | $53.42 | 2021-2023 | Tazverik |
| Fennec Pharmaceuticals, INC. | $50.04 | 2024 | Pedmark |
| Amag Pharmaceuticals, INC. | $49.28 | 2021 | |
| Celltrion USA INC. | $46.96 | 2023 | Vegzelma |
| Ge Healthcare | $46.35 | 2022 | |
| Beone Medicines USA, INC. | $46.06 | 2025 | Brukinsa |
| G1 Therapeutics, INC. | $41.37 | 2022-2023 | Cosela |
| Tolmar Pharmaceuticals, INC. | $40.98 | 2022 | |
| Spectrum Pharmaceuticals INC. | $39.81 | 2024-2025 | Rolvedon |
| Apellis Pharmaceuticals, INC. | $38.64 | 2022 | |
| Alnylam Pharmaceuticals INC. | $37.90 | 2024-2025 | Onpattro |
| Morphosys, US INC. | $35.49 | 2021-2022 | |
| Menarini Silicon Biosystems, INC. | $32.91 | 2023 | Cellsearch |
| Coherus Oncology, INC. | $30.47 | 2022 | |
| Novocure INC. | $28.83 | 2025 | Optune Lua (Novottf-200t) |
| Springworks Therapeutics, INC. | $25.39 | 2025 | Ogsiveo |
| Alexion Pharmaceuticals, INC. | $23.35 | 2025 | Ultomiris |
| Ipsen Biopharmaceuticals, INC | $23.00 | 2025 | Onivyde |
| Azurity Pharmaceuticals, INC. | $23.00 | 2024 | Vivimusta |
| Blue Earth Diagnostics | $21.98 | 2021 | |
| Tactile Systems Technology INC | $20.49 | 2022 | |
| Telix Pharmaceuticals | $20.08 | 2023 | Illuccix |
| Boston Scientific Corporation | $18.11 | 2021 | |
| Organon LLC | $16.44 | 2023 | Ontruzant |
| Accord Healthcare, INC. | $16.41 | 2024 | |
| Sanofi-Aventis U.S. LLC | $14.04 | 2021 | |
| Mayne Pharma Commercial LLC | $12.64 | 2021 | |
| Pharmaand Gmbh | $9.25 | 2025 | Rubraca |
Drugs and devices associated with these payments
Enhertu $651Keytruda $646Reblozyl $492Elrexfio $379Tukysa $375Verzenio $362Ojjaara $342Fotivda $337Jaypirca $312Pluvicto $311Ibrance $304Brukinsa $295Adcetris $292Trodelvy $277Lenvima $273Bosulif $266Doptelet $261Imfinzi $253Fruzaqla $250Erleada $248Kisqali $235Lynparza $223Imbruvica $223Opdivo $221Padcev $211Braftovi $204Jakafi $203Calquence $202Scemblix $196Zepzelca $191Darzalex $173Mektovi $173Monjuvi $169Gilotrif $164Libtayo $161Ninlaro $158Vonjo $157Opdualag $155Inlyta $155Xtandi $152Orgovyx $146Welireg $139Carvykti $138Venclexta $138Lorbrena $138Monoferric $135Tecentriq $129Tibsovo $125Polivy $118Rytelo $113Epkinly $113Alecensa $109Talvey $107Nubeqa $107Rezlidhia $103Tavalisse $103Avastin $102Orserdu $102Talzenna $97.86Tecvayli $95.42Tasigna $91.45Besremi $91.35Injectafer $91.31Piqray $89.22Datroway $85.32Intera 3000 Implantable Pump $81.64Vitrakvi $80.87Stivarga $80.87Enjaymo $80.60Pomalyst $78.16Cablivi $74.59Xt Cdx $74.54Zejula $74.26Fabhalta $72.49Besponsa $70.34Vyloy $69.20Neupogen $63.74Neulasta $63.74Krazati $61.89Mi Cancer Seek $60.80Kadcyla $57.40Phesgo $57.40Perjeta $57.40Jemperli $56.08Pyrukynd $55.09Rozlytrek $54.98Inqovi $54.77Lonsurf $54.77Bavencio $53.28Lutathera $52.66Poteligeo $51.00Retevmo $50.47Pedmark $50.04Tivdak $47.26Vegzelma $46.96Xospata $46.63Beleodaq $45.52Niktimvo $44.11Xpovio $43.05Cabometyx $41.59
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kathryn Bower listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.